【结 构 式】 |
【药物名称】Benatoprazole, Tenatoprazole, TU-199, Ulsacare, Protop 【化学名称】(±)-5-Methoxy-2-(4-methoxy-3,5-dimethylpyridin-2-ylmethylsulfinyl)imidazo[4,5-b]pyridine 【CA登记号】113712-98-4 【 分 子 式 】C16H18N4O3S 【 分 子 量 】346.41086 |
【开发单位】Mitsubishi Pharma (Originator), Abbott (Licensee), Negma (Licensee) 【药理作用】Antiulcer Drugs, Gastric Antisecretory Drugs, GASTROINTESTINAL DRUGS, H+/K+-ATPase Inhibitors |
合成路线1
The condensation of 2-mercapto-5-methoxy-3H-imidazo[4,5-b]pyridine (I) with 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine (II) by means of KOH in refluxing ethanol gives 2-(4-methoxy-3,5-dimethylpyridin-2-ylmethylthio)-5-methoxy-3H-imidazo [4,5-b]pyridine (III), which is then oxidized with m-chloroperbenzoic acid in chloroform.
【1】 Matsuichi, N.; Takeda, H.; Iizumi, K.; Murakami, K.; Hisamitsu, A. (Tokyo Tanabe Co., Ltd.); Imidazo[4,5-b]pyridine cpds., process for preparing same and pharmaceutical compsns. containing same. AU 8775628; EP 0254588; JP 1988146882 . |
【2】 Mealy, N.; Castañer, J.; Prous, J.; TU-199. Drugs Fut 1994, 19, 11, 1018. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 16520 | 5-methoxy-1H-imidazo[4,5-b]pyridine-2-thiol; 5-methoxy-1H-imidazo[4,5-b]pyridin-2-ylhydrosulfide | C7H7N3OS | 详情 | 详情 | |
(II) | 16521 | 2-(chloromethyl)-3,5-dimethyl-4-pyridinyl methyl ether; 2-(chloromethyl)-4-methoxy-3,5-dimethylpyridine; 2-Chloromethyl-3,5-dimethyl-4-methoxypyridine | 86604-75-3 | C9H12ClNO | 详情 | 详情 |
(III) | 16522 | 2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl]-1H-imidazo[4,5-b]pyridin-5-yl methyl ether; 5-methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfanyl]-1H-imidazo[4,5-b]pyridine | C16H18N4O2S | 详情 | 详情 |
Extended Information